Cell-Based Assays: Technologies and Global Markets

List of Tables

The global market for cell-based assays is estimated to increase from $35.3 billion in 2024 to reach $56.3 billion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

The consumables market for cell-based assays is estimated to increase from $19.9 billion in 2024 to reach $32.9 billion by 2029, at a CAGR of 10.6% from 2024 through 2029.

The instruments market for cell-based assays is estimated to increase from $8.7 billion in 2024 to reach $13.5 billion by 2029, at a CAGR of 9.3% from 2024 through 2029.

Report Scope

The scope of this report on the global market for cell-based assay technologies encompasses an analysis of the current landscape, including market size, growth trends and segmentation by product type, application and end user. The report breaks down the cell-based assay market into four product categories: instruments, consumables, services, and software. It also segments the market by application, such as drug discovery; absorption, distribution, metabolism, and excretion (ADME)/toxicity testing; and basic research. The end users considered in the report include academic and research institutions, pharmaceutical and biotech companies, and clinical research organizations.

Geographically, the analysis covers North America, Europe, Asia-Pacific, and Rest of the World (RoW). The report also provides profiles of key market players and highlights industry trends, major products, mergers and acquisitions, and other partnerships expected to influence the future of the industry.

Report Includes

23 data tables and 48 additional tables
Analyses of the trends in the global market for cell-based assays, with sales data for 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
Evaluation of the market's current and future potential
Estimates of the market for cell-based assays, revenue forecasts, and corresponding market share analysis by product, type/application, end user and geographic region
Assessment of the current market, new developments, spending trends, and revenue prospects for cell-based assays in the pharmaceutical industry
Coverage of major issues involved in the R&D of more effective cell-based approaches for drug discovery
Information on increasing investments in R&D activities, key technology issues, industry-specific challenges, major types of end users, and COVID-19 implications
Discussion of ESG challenges and practices of the industry
Assessment of the competitive landscape, including the market shares of leading companies, their product portfolios and financial overviews
Information on recent mergers and acquisitions, expansions, collaborations, investments, divestments and product launches
Company profiles of major players within the industry, including Thermo Fisher Scientific Inc., Merck KGaA., Danaher Corp., Bio-Rad Laboratories Inc., and Charles River Laboratories.

Product Code: BIO080F

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Summary

Chapter 2 Market Overview

Overview
Drug Discovery
Importance of Cell-based Assays
Cell Signaling Pathways
Mechanisms of Drug Action
Gene Expression Regulation
Cytotoxicity and Viability
Disease Modeling
Types of Cell-based Assays
Cell Viability Assays
Cell Proliferation Assays
Cytotoxicity Assays
Application of Cell-based Assays
Drug Discovery and Development
Toxicology Studies
Cancer Research
Infectious Disease Research
Immunology and Inflammation
Molecular Pathway Analysis
Regenerative Medicine and Tissue Engineering
Biomarker Discovery and Validation
Precision and Personalized Medicine

Chapter 3 Market Dynamics

Overview
Market Drivers
Rising Incidence of Chronic Diseases
Rising Demand for Drug Discovery and Development
High Demand for Personalized Medicine
Increasing Investment in Drug R&D
Market Restraints
High Cost of Assay Development and Maintenance
Technical Challenges and Complexity
Short Shelf-life of Reagents and Consumables
Market Opportunities
Expanding Applications in Drug Discovery
Expansion in Diagnostics and Biomarker Discovery

Chapter 4 Emerging Technologies and Developments

Overview
Emerging Technologies
CRISPR/Cas9 Technology
High-content Screening (HCS) and Imaging
AI and Machine Learning (ML) in Data Analysis
Patent Analysis
Patent Review, by Leading Jurisdiction

Chapter 5 Market Segmentation Analysis

Overview
Segmentation Breakdown
Cell-based Assays: Global Markets
Market Analysis by Product Type
Consumables
Instruments
Software
Services
Market Analysis by Application
Drug Discovery
Absorption, Distribution, Metabolism, and Excretion (ADME)/Toxicity
Basic Research
Market Analysis by End User
Biotechnology and Pharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations
Geographic Breakdown
Market Analysis by Region
North America
Europe
Asia-Pacific
Rest of the World

Chapter 6 Competitive Intelligence

Competitive Landscape
Ranking of Companies in the Cell-based Assay Market

Chapter 7 Sustainability in Cell-based Assay Market: An ESG Perspective

Sustainability in the Cell-based Assay Market
Animal Testing
Miniaturization and Automation
Green Chemistry and Eco-friendly Materials
3D Cell Cultures and Tissue Models
Waste Reduction and Optimization of Resources
Improving Drug Discovery Efficiency
ESG Risks and Ratings: Understanding the Data
BCC Research Viewpoint

Chapter 8 Appendix

Methodology
Sources
Abbreviations
Company Profiles
AGILENT TECHNOLOGIES INC.
BD
BIOIVT
BIO-RAD LABORATORIES INC.
CELL BIOLABS INC.
CELL BIOLOGICS INC.
CHARLES RIVER LABORATORIES
DANAHER CORP.
FUJIFILM HOLDINGS CORP.
GE HEALTHCARE
LONZA
MERCK KGAA
PROMEGA CORP.
REVVITY
THERMO FISHER SCIENTIFIC INC.

Product Code: BIO080F

List of Tables

Summary Table A : Global Market for Cell-based Assays, by Product Type, Through 2029
Summary Table B : Global Market for Cell-based Assays, by Region, Through 2029
Table 1 : Factors in Cell-based Assay Development
Table 2 : Types of Cellular Assays
Table 3 : New Cases and Deaths Due to Selected Cancers Globally, 2022
Table 4 : U.S. NIH Funding for Selected Diseases, 2019-2023
Table 5 : Existing Cell-based Assay Technologies
Table 6 : Patents Issued for Cell-based Assays, by Jurisdiction, 2022-2024
Table 7 : Global Market for Cell-based Assays, Through 2029
Table 8 : Global Market for Cell-based Assays, by Product Type, Through 2029
Table 9 : Global Market for Cell-based Assays, by Application, Through 2029
Table 10 : Global Market for Cell-based Assays, by End User, Through 2029
Table 11 : Global Market for Cell-based Assays, by Region, Through 2029
Table 12 : North American Market for Cell-based Assays, by Country, Through 2029
Table 13 : European Market for Cell-based Assays, by Country, Through 2029
Table 14 : Asia-Pacific Market for Cell-based Assays, by Country, Through 2029
Table 15 : RoW Market for Cell-based Assays, by Subregion, Through 2029
Table 16 : Ranking of Companies in Cell-based Assay Market, 2023
Table 17 : ESG Rankings for Major Cell-based Assay Companies, 2024*
Table 18 : Information Sources in This Report
Table 19 : Abbreviations Used in this Report
Table 20 : Agilent Technologies Inc.: Company Snapshot
Table 21 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 22 : Agilent Technologies Inc.: Product Portfolio
Table 23 : Agilent Technologies Inc.: News/Key Developments, 2024
Table 24 : BD: Company Snapshot
Table 25 : BD: Financial Performance, FY 2023 and 2024
Table 26 : BD: Product Portfolio
Table 27 : BD: News/Key Developments, 2024
Table 28 : BioIVT: Company Snapshot
Table 29 : BioIVT: Product Portfolio
Table 30 : BioIVT: News/Key Developments, 2023 and 2024
Table 31 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 32 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 33 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 34 : Bio-Rad Laboratories Inc.: News/Key Developments, 2021-2024
Table 35 : Cell Biolabs Inc.: Company Snapshot
Table 36 : Cell Biolabs Inc.: Product Portfolio
Table 37 : Cell Biologics Inc.: Company Snapshot
Table 38 : Cell Biologics Inc.: Product Portfolio
Table 39 : Charles River Laboratories: Company Snapshot
Table 40 : Charles River Laboratories: Financial Performance, FY 2022 and 2023
Table 41 : Charles River Laboratories: Product Portfolio
Table 42 : Charles River Laboratories: News/Key Developments, 2023 and 2024
Table 43 : Danaher Corp.: Company Snapshot
Table 44 : Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 45 : Danaher Corp.: Product Portfolio
Table 46 : Fujifilm Holdings Corp.: Company Snapshot
Table 47 : Fujifilm Holdings Corp.: Financial Performance, FY 2022 and 2023
Table 48 : Fujifilm Holdings Corp.: Product Portfolio
Table 49 : GE Healthcare: Company Snapshot
Table 50 : GE Healthcare: Financial Performance, FY 2022 and 2023
Table 51 : GE Healthcare: Product Portfolio
Table 52 : Lonza: Company Snapshot
Table 53 : Lonza: Financial Performance, FY 2022 and 2023
Table 54 : Lonza: Product Portfolio
Table 55 : Lonza: News/Key Developments, 2021
Table 56 : Merck KGaA: Company Snapshot
Table 57 : Merck KGaA: Financial Performance, FY 2022 and 2023
Table 58 : Merck KGaA: Product Portfolio
Table 59 : Promega Corp.: Company Snapshot
Table 60 : Promega Corp.: Product Portfolio
Table 61 : Promega Corp.: News/Key Developments, 2023
Table 62 : Revvity: Company Snapshot
Table 63 : Revvity: Financial Performance, FY 2022 and 2023
Table 64 : Revvity: Product Portfolio
Table 65 : Revvity: News/Key Developments, 2023 and 2024
Table 66 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 67 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 68 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 69 : Thermo Fisher Scientific Inc.: News/Key Developments, 2023 and 2024

List of Figures

Summary Figure A : Global Market for Cell-based Assays, by Product Type, 2021-2029
Summary Figure B : Global Market for Cell-based Assays, by Region, 2021-2029
Figure 1 : Projected Global Aging Population (65 Years and Above), 1990-2050
Figure 2 : Drug Discovery Process Steps
Figure 3 : Market Dynamics of Cell-based Assays
Figure 4 : FDA Approval of Personalized Medicines, 2015-2022
Figure 5 : Pharmaceutical R&D Spending, by Country/Region, 2010-2022
Figure 6 : Shares of Global Market for Cell-based Assays, by Product Type, 2023
Figure 7 : Shares of Global Market for Cell-based Assays, by Application, 2023
Figure 8 : Shares of Global Market for Cell-based Assays, by End User, 2023
Figure 9 : R&D Spending of Biopharmaceutical Companies, 2010-2024
Figure 10 : Shares of Global Market for Cell-based Assays, by Region, 2023
Figure 11 : Shares of North American Market for Cell-based Assays, by Country, 2023
Figure 12 : Shares of European Market for Cell-based Assays, by Country, 2023
Figure 13 : Shares of Asia-Pacific Market for Cell-based Assays, by Country, 2023
Figure 14 : Shares of RoW Market for Cell-based Assays, by Subregion, 2023
Figure 15 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
Figure 16 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023
Figure 17 : BD: Revenue Share, by Business Unit, FY 2024
Figure 18 : BD: Revenue Share, by Country/Region, FY 2024
Figure 19 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
Figure 20 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
Figure 21 : Charles River Laboratories: Revenue Share, by Business Unit, FY 2023
Figure 22 : Charles River Laboratories: Revenue Share, by Country/Region, FY 2023
Figure 23 : Danaher Corp.: Revenue Share, by Business Unit, FY 2023
Figure 24 : Danaher Corp.: Revenue Share, by Country/Region, FY 2023
Figure 25 : Fujifilm Holdings Corp.: Revenue Share, by Business Unit, FY 2023
Figure 26 : Fujifilm Holdings Corp.: Revenue Share, by Country/Region, FY 2023
Figure 27 : GE Healthcare: Revenue Share, by Business Unit, FY 2023
Figure 28 : GE Healthcare: Revenue Share, by Country/Region, FY 2023
Figure 29 : Lonza: Revenue Share, by Business Unit, FY 2023
Figure 30 : Merck KGaA: Revenue Share, by Business Unit, FY 2023
Figure 31 : Merck KGaA: Revenue Share, by Country/Region, FY 2023
Figure 32 : Revvity: Revenue Share, by Business Unit, FY 2023
Figure 33 : Revvity: Revenue Share, by Country/Region, FY 2023
Figure 34 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, 2023
Figure 35 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, 2023

Cell-Based Assays: Technologies and Global Markets

Description

Table of Contents

List of Tables

Report Scope

Report Includes

Table of Contents

Chapter 1 Executive Summary

Chapter 2 Market Overview

Chapter 3 Market Dynamics

Chapter 4 Emerging Technologies and Developments

Chapter 5 Market Segmentation Analysis

Chapter 6 Competitive Intelligence

Chapter 7 Sustainability in Cell-based Assay Market: An ESG Perspective

Chapter 8 Appendix

List of Tables

List of Figures